Ketamine Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT04912115
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 5, 2021
Completion: Mar 30, 2024
Loading map...